Further the genetic alterations results of CDH23 in DLBCL showed that there was a missense mutation of CDH23 in 0.2% DLBCL samples, and the genetic altered frequency in the CDH23 altered group was higher than that in the CDH23 unaltered group. The gene discussed is CDH23; the disease is diffuse large B-cell lymphoma.